Prosigna®/pam50 en la toma de decisiones clinicas en pacientes con cancer de mama

28 / 31

Genomic platforms:potenial clinical
applications in breast cancer
prognostication
prediction of
response to
hormones
prediction of
response to
chemotherapy
Prediction of
response to
specific CT drugs
Prediction of
response to
targeted therapies